CASI - CASI Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08 revenue of $10.21M beats by $0.3M
- CASI Pharmaceuticals press release ( NASDAQ: CASI ): Q3 GAAP EPS of -$0.38 beats by $0.08 .
- Revenue of $10.21M (+25.9% Y/Y) beats by $0.3M .
For further details see:
CASI Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08, revenue of $10.21M beats by $0.3M